Raymond F. Schinazi is an American organic medicinal chemist with expertise in antiviral agents, pharmacology, and biotechnology. His research focuses on developing treatments for infections caused by human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), herpes, dengue fever, zika, chikungunya, and other emerging viruses. These treatment options include antiviral agents as well as synthetic, biochemical, pharmacological and molecular genetic approaches, in… WebRaymond F Schinazi Net Worth 2024 and insider trades. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, ... S&P 500 Aggregate Buffett …
King of the pills Science
WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $11,128,692 and over the last 8 years Raymond sold DTIL … WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $8,749,454 and over the last 8 years Raymond sold DTIL … portland blazers logo png
Raymond F Schinazi, 72 - Tucker, GA - Reputation & Contact Details
WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $9,440,201 and over the last 8 years Raymond sold DTIL stock worth over $1,696,250 WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least $15 Million dollars as of 4 May 2024. Raymond Schinazi owns over 575,000 units of Precision BioSciences stock worth over $13,277,681 and over the last 7 years Raymond sold DTIL stock worth over $1,696,250. WebSchinazi is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including Pharmasset Inc., Triangle Pharmaceuticals (acquired by Gilead in 2003), Idenix Pharmaceuticals (51% acquired by Novartis in 2003), and RFS Pharma LLC (formed in Sept 2004). He holds more than 70 US patents. portland blazers cj